Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Can rodent kidney models really simulate the clinic?

With Dr Wioletta Pijacka, Study Director, In vivo pharmacology, Sygnature Discovery

Chronic kidney diseases remain a major unmet clinical need. Animal models are used to evaluate the therapeutic potential of novel candidate drugs, however developing animal models with strong predictive validity remains a challenge. Due to the complexity of human renal pathologies, it is imperative that the nuances of each model are taken into careful consideration to ensure the best chance of success.

View Webinar

Webinar Data Capture

Latest Webinars

View All

Mouse Models of Cancer: understand their limitations…

To Control or be Controlled: Navigating the…

How DMPK should integrate with and influence…

Rethinking Diabetes Drug Discovery

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.